Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · REGISTER · 2020-05-22 · DEPARTMENT OF JUSTICE · Notices

Notices. Notice of application

290 words·~1 min read·/register/2020/05/22/2020-11077

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4410-11-P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-645] Bulk Manufacturer of Controlled Substances Application: Noramco, Inc. ACTION: Notice of application. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before July 21, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention:
DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on February 26, 2020, Noramco, Inc., 500 Swedes Landing Road, Wilmington, Delaware 19801-4417, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances: Controlled substance Drug code Schedule Marihuana 7360 I Tetrahydrocannabinols 7370 I Codeine-N-oxide 9053 I Dihydromorphine 9145 I Hydromorphinol 9301 I Morphine-N-oxide 9307 I Amphetamine 1100 II Lisdexamfetamine 1205 II Methylphenidate 1724 II Nabilone 7379 II Phenylacetone 8501 II Codeine 9050 II Dihydrocodeine 9120 II Oxycodone 9143 II Hydromorphone 9150 II Hydrocodone 9193 II Morphine 9300 II Oripavine 9330 II Thebaine 9333 II Opium extracts 9610 II Opium fluid extract 9620 II Opium tincture 9630 II Opium, powdered 9639 II Opium, granulated 9640 II Oxymorphone 9652 II Noroxymorphone 9668 II Tapentadol 9780 II The company plans to manufacture the listed controlled substances as an Active Pharmaceutical Ingredient
(API)for supply to its customers. In reference to drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetics. No other activities for these drug codes are authorized for this registration. This notice does not constitute an evaluation or determination of the merits of the company's application. William T. McDermott, Assistant Administrator. [FR Doc. 2020-11077 Filed 5-21-20; 8:45 am]
Connectionstraces to 1
Citation graph
cites case law
Notices
Notice of application
Cites 1Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.